Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a
- 1 February 2006
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (1) , 98-102
- https://doi.org/10.1016/j.ejso.2005.10.007
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?Surgery, 2003
- Early Malignant Progression of Hereditary Medullary Thyroid CancerNew England Journal of Medicine, 2003
- CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2Journal of Clinical Endocrinology & Metabolism, 2001
- Multiple endocrine neoplasia type 2B — genetic basis and clinical expressionPublished by Elsevier ,2001
- Genetic Testing in Presymptomatic Diagnosis of Multiple Endocrine NeoplasiaHormone Research, 1997
- The Men II Syndromes and the Role of the ret Proto-oncogeneAdvances in Cancer Research, 1996
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- RISK ESTIMATION AND SCREENING IN FAMILIES OF PATIENTS WITH MEDULLARY THYROID CARCINOMAThe Lancet, 1988
- Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entityBritish Journal of Surgery, 1986